ConductScience.org, home

Paper37342192

Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities.

Araki S and 2 others. Front Oncol, 2023. Cited by 21 papers, by iCite.

Cite this record

ConductScience Library. Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities. Papers, record 37342192. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37342192

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities.
PubMed
Journal
Front Oncol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
21
iCite
Relative citation ratio, by iCite
1.72
iCite
Revised in PubMed
2023-07-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Araki SShinsuke
2Ohori MMomoko
3Yugami MMasato

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References199

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121205200Serine-arginine protein kinases: a small protein kinase family with a large cellular presence.FEBS J2011https://conductscience.org/library/papers/21205200PubMed
231408619Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation.Cancer Cell2019https://conductscience.org/library/papers/31408619PubMed
321536904Interaction between the RNA binding domains of Ser-Arg splicing factor 1 and U1-70K snRNP protein determines early spliceosome assembly.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21536904PubMed
424007862Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells.Cancer Lett2014https://conductscience.org/library/papers/24007862PubMed
520967262Expression of conjoined genes: another mechanism for gene regulation in eukaryotes.PLoS One2010https://conductscience.org/library/papers/20967262PubMed
628466384Splicing factor mutations in MDS RARS and MDS/MPN-RS-T.Int J Hematol2017https://conductscience.org/library/papers/28466384PubMed
729266803Structure-Based Design of Selective Noncovalent CDK12 Inhibitors.ChemMedChem2018https://conductscience.org/library/papers/29266803PubMed
829358035EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma.Cancer Cell2018https://conductscience.org/library/papers/29358035PubMed
926566663The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.EMBO Rep2015https://conductscience.org/library/papers/26566663PubMed
1026500332Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion.J Clin Pathol2016https://conductscience.org/library/papers/26500332PubMed
1123707382Partitioning RS domain phosphorylation in an SR protein through the CLK and SRPK protein kinases.J Mol Biol2013https://conductscience.org/library/papers/23707382PubMed
1227282251Upregulation of p27 cyclin-dependent kinase inhibitor and a C-terminus truncated form of p27 contributes to G1 phase arrest.Sci Rep2016https://conductscience.org/library/papers/27282251PubMed
1331479715Circular RNA circ-PRMT5 facilitates non-small cell lung cancer proliferation through upregulating EZH2 via sponging miR-377/382/498.Gene2019https://conductscience.org/library/papers/31479715PubMed
1432359191A conserved sequence motif bridges two protein kinases for enhanced phosphorylation and nuclear function of a splicing factor.FEBS J2021https://conductscience.org/library/papers/32359191PubMed
1527622333Physiologic Expression of Sf3b1(K700E) Causes Impaired Erythropoiesis, Aberrant Splicing, and Sensitivity to Therapeutic Spliceosome Modulation.Cancer Cell2016https://conductscience.org/library/papers/27622333PubMed
1634092037Oncogenic dysregulation of pre-mRNA processing by protein kinases: challenges and therapeutic opportunities.FEBS J2021https://conductscience.org/library/papers/34092037PubMed
1724498085A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.PLoS One2014https://conductscience.org/library/papers/24498085PubMed
1828488700Alternative splicing as a regulator of development and tissue identity.Nat Rev Mol Cell Biol2017https://conductscience.org/library/papers/28488700PubMed
1927397683Release of SR Proteins from CLK1 by SRPK1: A Symbiotic Kinase System for Phosphorylation Control of Pre-mRNA Splicing.Mol Cell2016https://conductscience.org/library/papers/27397683PubMed
2025010863Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma.Br J Cancer2014https://conductscience.org/library/papers/25010863PubMed

See all 199 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 21 citations.

PMIDTitleJournalYearIn PapersSource
42942016Lipid Metabolism and Ferroptosis in Cancer: Regulatory Mechanisms, Alternative Splicing, and Therapeutic Implications.Int J Mol Sci2026https://conductscience.org/library/papers/42942016PubMed
42819770mRNA processing in cancer immunotherapy: emerging targets, resistance mechanisms, and therapeutic opportunities.Front Immunol2026https://conductscience.org/library/papers/42819770PubMed
41771572SNRPD2-dependency Fuels an Oncogenic Alternative Splicing Repertoire Driving Disease Aggressiveness in Glioma.Cancer Genomics Proteomics2026https://conductscience.org/library/papers/41771572PubMed
41403742Serine/Arginine Protein Kinase Inhibitors Potentiate Melanoma Cell Death and Metastatic Inhibition Through Apoptotic Protein Triggering and Vimentin Dysregulation.Adv Pharm Bull2025https://conductscience.org/library/papers/41403742PubMed
41279615Discovery of small molecule probes targeting the 5' stem-loop in the yeast U4/U6 snRNA.bioRxiv2025https://conductscience.org/library/papers/41279615PubMed
41112581Targeting RNA-binding proteins with small molecules: perspectives and challenges.Front Chem2025https://conductscience.org/library/papers/41112581PubMed
40300107Integrated Computational and Functional Screening Identifies G9a Inhibitors for SETD2-mutant Leukemia.Genomics Proteomics Bioinformatics2025https://conductscience.org/library/papers/40300107PubMed
40287469Comprehensive analysis of splicing variants in corneal endothelial cells of patients with Fuchs endothelial corneal dystrophy.Sci Rep2025https://conductscience.org/library/papers/40287469PubMed
40176684The Development of Selective Chemical Probes for Serine Arginine Protein Kinase 3.Chem Biol Drug Des2025https://conductscience.org/library/papers/40176684PubMed
40141064Zα and Zβ Localize ADAR1 to Flipons That Modulate Innate Immunity, Alternative Splicing, and Nonsynonymous RNA Editing.Int J Mol Sci2025https://conductscience.org/library/papers/40141064PubMed
40140908C9ORF72 poly-PR disrupts expression of ALS/FTD-implicated STMN2 through SRSF7.Acta Neuropathol Commun2025https://conductscience.org/library/papers/40140908PubMed
40000711Establishment of an alternative splicing prognostic risk model and identification of FN1 as a potential biomarker in glioblastoma multiforme.Sci Rep2025https://conductscience.org/library/papers/40000711PubMed
39770502Boronic Acid-Containing 3H- pyrazolo[4,3-f]quinoline Compounds as Dual CLK/ROCK Inhibitors with Anticancer Properties.Pharmaceuticals (Basel)2024https://conductscience.org/library/papers/39770502PubMed
39218979The roles and mechanisms of coding and noncoding RNA variations in cancer.Exp Mol Med2024https://conductscience.org/library/papers/39218979PubMed
38904016Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.Int J Biol Sci2024https://conductscience.org/library/papers/38904016PubMed
38884552Dysregulation of the TCF4 Isoform in Corneal Endothelial Cells of Patients With Fuchs Endothelial Corneal Dystrophy.Invest Ophthalmol Vis Sci2024https://conductscience.org/library/papers/38884552PubMed
38753413The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune response.Oncotarget2024https://conductscience.org/library/papers/38753413PubMed
38658776Alternative splicing in prostate cancer progression and therapeutic resistance.Oncogene2024https://conductscience.org/library/papers/38658776PubMed
37568815Alternative Splicing Events and Their Clinical Significance in Colorectal Cancer: Targeted Therapeutic Opportunities.Cancers (Basel)2023https://conductscience.org/library/papers/37568815PubMed

Download CSV of cited by

Genes93

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
ABCB610058PubTator's text mininghttps://conductscience.org/library/genes/10058NCBI Gene
ABCG29429PubTator's text mininghttps://conductscience.org/library/genes/9429NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ASPH444PubTator's text mininghttps://conductscience.org/library/genes/444NCBI Gene
ATR545PubTator's text mininghttps://conductscience.org/library/genes/545NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BRCA1672PubTator's text mininghttps://conductscience.org/library/genes/672NCBI Gene
BRCA2675PubTator's text mininghttps://conductscience.org/library/genes/675NCBI Gene
BRD423476PubTator's text mininghttps://conductscience.org/library/genes/23476NCBI Gene
CCNE1898PubTator's text mininghttps://conductscience.org/library/genes/898NCBI Gene
CCNE29134PubTator's text mininghttps://conductscience.org/library/genes/9134NCBI Gene
CCNG1900PubTator's text mininghttps://conductscience.org/library/genes/900NCBI Gene
CCNK8812PubTator's text mininghttps://conductscience.org/library/genes/8812NCBI Gene
CCNL157018PubTator's text mininghttps://conductscience.org/library/genes/57018NCBI Gene
CD1648763PubTator's text mininghttps://conductscience.org/library/genes/8763NCBI Gene
CDK11A728642PubTator's text mininghttps://conductscience.org/library/genes/728642NCBI Gene
CDK11B984PubTator's text mininghttps://conductscience.org/library/genes/984NCBI Gene

See all 93 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37342192

GET https://conductscience.org/api/papers/v1/37342192/references?page=2